Granules Pharmaceuticals Inc.: Drug Recall
Recall #D-0305-2026 · 01/26/2026
Class II: Risk
Recall Details
- Recall Number
- D-0305-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Granules Pharmaceuticals Inc.
- Status
- Ongoing
- Date Initiated
- 01/26/2026
- Location
- Chantilly, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 71424 bottles.
Reason for Recall
Presence of Foreign Tablets/Capsules
Product Description
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.
Distribution Pattern
US Nationwide.
Other Recalls by Granules Pharmaceuticals Inc.
- Class III: Low Risk 08/28/2025
- Class III: Low Risk 08/28/2025
- Class III: Low Risk 08/28/2025
- Class III: Low Risk 08/28/2025
- Class III: Low Risk 08/28/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.